This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Samjin Pharmaceutical Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Song I Yang: Innovator in JNK Inhibitory Activity
Introduction
Song I Yang is a notable inventor based in Gyeongsangnam-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work focuses on innovative solutions for treating degenerative brain nervous system diseases.
Latest Patents
One of Song I Yang's key patents is titled "Imidazole derivative having JNK inhibitory activity and use thereof." This invention relates to a novel imidazole derivative that exhibits excellent inhibitory activity against C-Jun N-terminal kinase (JNK). The potential applications of this compound are promising, as it may lead to more effective prevention and treatment strategies for various neurodegenerative conditions.
Career Highlights
Song I Yang is currently associated with Samjin Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic approaches in neurology.
Collaborations
Throughout his career, Song I Yang has collaborated with talented individuals such as Jung-Mi Hah and Jung Hun Lee. These partnerships have contributed to the success of his research initiatives and the advancement of innovative pharmaceutical solutions.
Conclusion
In summary, Song I Yang is a distinguished inventor whose work in developing JNK inhibitory compounds holds great promise for the treatment of neurodegenerative diseases. His contributions to the field of pharmaceuticals are noteworthy and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile